Updates are available Correction dated 2025-08-21
Click to view Correction: https://doi.org/10.1186/s40478-025-02094-w
-
Authors
Okonechnikov, Konstantin
Ghasemi, David R.
Schrimpf, Daniel
Tonn, Svenja
Mynarek, Martin
Koster, Jan
Milde, Till
Zheng, Tuyu
Sievers, Philipp
Sahm, Felix
Jones, David T.W.
von Deimling, Andreas
Pfister, Stefan M.
Kool, Marcel
Pajtler, Kristian W.
Korshunov, Andrey
-
Funding
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
- License Information
-
More Information
Article History
Received: 23 October 2024
Accepted: 23 December 2024
First Online: 7 January 2025
Change Date: 7 August 2025
Change Type: Update
Change Details: The original online version of this article was revised: Fig. 1 appeared incorrect and correct version has been updated.
Change Date: 21 August 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40478-025-02094-w
Declarations
:
: The study was conducted under the auspices of the local Ethics Committees, in compliance with German rules of the Health Insurance Portability.
: All authors have approved the manuscript and agree with its submission.
: Felix Sahm is co-founder and shareholder of Heidelberg Epignostix GmbH.
